Skip to main content
. 2018 Apr 20;10(4):678–691. doi: 10.1080/19420862.2018.1452580

Figure 2.

Figure 2.

Physicochemical Properties of Size and Charge Variants, as Assessed by SE-HPLC (a), rCE-SDS (b), CEX-HPLC (c), and cIEF (d) for ABP 215 (□), bevacizumab (US) (∆), and bevacizumab (EU) (○).